APA

Hampton A., Kappler F., Maeda M. & Patel A. D. (19790223). Use of adenine nucleotide derivatives to assess the potential of exo-active-site-directed reagents as species- or isozyme-specific enzyme inactivators. 2. Isozyme-specific inactivation of a mammalian enzyme and its significance in the possible design of fetal isozyme targeted antineoplastic agents. : Journal of medicinal chemistry.

Chicago

Hampton A, Kappler F, Maeda M and Patel A D. 19790223. Use of adenine nucleotide derivatives to assess the potential of exo-active-site-directed reagents as species- or isozyme-specific enzyme inactivators. 2. Isozyme-specific inactivation of a mammalian enzyme and its significance in the possible design of fetal isozyme targeted antineoplastic agents. : Journal of medicinal chemistry.

Harvard

Hampton A., Kappler F., Maeda M. and Patel A. D. (19790223). Use of adenine nucleotide derivatives to assess the potential of exo-active-site-directed reagents as species- or isozyme-specific enzyme inactivators. 2. Isozyme-specific inactivation of a mammalian enzyme and its significance in the possible design of fetal isozyme targeted antineoplastic agents. : Journal of medicinal chemistry.

MLA

Hampton A, Kappler F, Maeda M and Patel A D. Use of adenine nucleotide derivatives to assess the potential of exo-active-site-directed reagents as species- or isozyme-specific enzyme inactivators. 2. Isozyme-specific inactivation of a mammalian enzyme and its significance in the possible design of fetal isozyme targeted antineoplastic agents. : Journal of medicinal chemistry. 19790223.